Heron Therapeutics
HRTX
#9790
Rank
$79.02 M
Marketcap
$0.42
Share price
7.80%
Change (1 day)
-79.13%
Change (1 year)

Market capitalization of Heron Therapeutics (HRTX)

Market cap: $79.02 Million USD

As of June 2026 Heron Therapeutics has a market cap of $79.02 Million USD. This makes Heron Therapeutics the world's 9790th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Heron Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026$79.02 M-66.33%
2025$0.23 B-0.44%
2024$0.23 B-7.6%
2023$0.25 B-14.16%
2022$0.29 B-68.06%
2021$0.93 B-51.84%
2020$1.93 B-8.93%
2019$2.12 B4.65%
2018$2.02 B74.56%
2017$1.16 B126.29%
2016$0.51 B-46.75%
2015$0.96 B227.88%
2014$0.29 B40.15%
2013$0.20 B27.36%
2012$0.16 B258.05%
2011$46 M153.99%
2010$18.11 M-64%
2009$50.31 M287.2%
2008$12.99 M-73.29%
2007$48.65 M39.6%
2006$34.85 M-9.9%
2005$38.67 M-6.36%
2004$41.3 M-18.32%
2003$50.57 M147.09%
2002$20.46 M-64.09%
2001$56.99 M18.78%
2000$47.98 M-30.62%
1999$69.16 M-35.63%
1998$0.10 B-16.67%
1997$0.12 B-7.89%
1996$0.13 B

End of Day market cap according to different sources

On Jun 19th, 2026 the market cap of Heron Therapeutics was reported to be:

$79.02 Million USD
by Nasdaq info icon info icon
$79.02 Million USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
SurModics
SRDX
$0.61 B 677.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
$0.87 B 1,011.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$5.50 B 6,871.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
$7.49 B 9,389.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
$2.06 B 2,507.14%๐Ÿ‡บ๐Ÿ‡ธ USA